Vital KSK Holdings, Inc.

3151

JP3778280002

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-31 am EDT			5-day change	1st Jan Change
1,356 ^JPY	+2.96%		+9.53%	+29.89%

May. 15	Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	MT
May. 15	Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	MT

Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.

May 13, 2024 at 01:00 am EDT

Vital KSK Holdings, Inc. (TSE:3151) announces a share repurchase program. Under the program, the company will repurchase up to 2,000,000 shares, representing 3.85% of its issued share capital (excluding treasury stock), for a total purchase price of ¥3,000 million. The purpose of the program is improving capital efficiency, implementing flexible capital policies in response to changes in the business environment, and returning profits to shareholders.

The program will be valid till March 24, 2025. As of March 31, 2024, the company had 51,902,976 issued shares (excluding treasury stock) and 1,599,958 treasury shares.

Latest news about Vital KSK Holdings, Inc.

Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	May. 15	MT
Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	May. 14	MT
Vital KSK Board OKs Up to 3 Billion Yen Share Buyback	May. 14	MT
Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2025	May. 13	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.	May. 13	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	May. 12	CI
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	Feb. 07	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	Nov. 07	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million.	Nov. 07	CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023	Nov. 06	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 06	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.	Nov. 06	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	Nov. 05	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-09-24	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million.	23-09-21	CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	23-08-03	CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-08-03	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	23-07-03	CI
Vital KSK Announces Voting Results	23-06-30	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 1,000,000 shares, for ¥1,200 million.	23-05-12	CI

Chart Vital KSK Holdings, Inc.

Duration

Period

More charts

Company Profile

VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.

Sector

Pharmaceuticals

Calendar

2024-07-29 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
VITAL KSK HOLDINGS, INC.	+29.89%	433M
MCKESSON CORPORATION	+23.03%	74.04B
CARDINAL HEALTH, INC.	-1.52%	24.18B
SINOPHARM GROUP CO. LTD.	+3.67%	8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+8.55%	8.34B
HUADONG MEDICINE CO., LTD	-23.71%	7.64B
H. LUNDBECK A/S	+15.20%	5.33B
GALENICA AG	+2.68%	4.12B
EBOS GROUP LIMITED	-6.90%	3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+5.56%	3.89B

Pharmaceuticals Wholesale